Table 3.
Compound ID | Percent protection |
||
---|---|---|---|
3 h | 6 h | 12 h | |
4 | 39.14 ± 0.02⁎,⁎⁎ | 56.26 ± 0.04⁎,⁎⁎ | 51.41 ± 0.24⁎,⁎⁎ |
5 | 41.75 ± 0.65⁎,⁎⁎ | 62.83 ± 0.61⁎,⁎⁎ | 58.15 ± 0.06⁎,⁎⁎ |
6 | 27.2 ± 0.01⁎,⁎⁎ | 38.15 ± 0.04⁎,⁎⁎ | 36.41 ± 0.25⁎,⁎⁎ |
7 | 36.58 ± 0.47⁎,⁎⁎ | 44.62 ± 0.09⁎,⁎⁎ | 49.71 ± 0.34⁎,⁎⁎ |
8 | 27.92 ± 0.3⁎,⁎⁎ | 41.14 ± 0.07⁎,⁎⁎ | 39.61 ± 0.67⁎,⁎⁎ |
9 | 23.27 ± 0.71⁎,⁎⁎ | 31.34 ± 0.06⁎,⁎⁎ | 35.78 ± 0.86⁎,⁎⁎ |
10 | 20.56±.03⁎,⁎⁎ | 27.47 ± 0.03⁎,⁎⁎ | 34.58 ± 0.43⁎,⁎⁎ |
11 | 19.25 ± 0.71⁎,⁎⁎ | 28.16 ± 0.02⁎,⁎⁎ | 25.52 ± 0.6⁎,⁎⁎ |
Ibuprofen (standard) | 68.12 ± 0.61⁎ | 69.91 ± 0.74⁎ | 67.54 ± 0.07⁎ |
Significant difference from negative control and ibuprofen (standard), respectively at P < 0.0001, using Tukey’s test as post ANOVA test.